GL1X · GenesisL1 explorer

MolNFT v1 · #166857 · protein

Crystal structure of braf V600E oncogenic mutant in complex with tak- 580

6V34 · SERINE/THREONINE-protein kinase B-RAF: “Crystal structure of braf V600E oncogenic mutant in complex with tak- 580”. X-ray diffraction, 1 ligand (QOP), 6 pockets (best druggability 0.73). MolNFT v1 #166857 on GenesisL1: 3D structure…

PDB
6V34
Type
protein
Length
503 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase B-RAF
UniProt
A0A2R8Y8E0
Ligands
QOP
Pockets
6 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase B-RAFprotein25638% helix, 17% strandA0A2R8Y8E0
BSERINE/THREONINE-protein kinase B-RAFprotein24739% helix, 16% strandA0A2R8Y8E0

Ligands and binding sites

  • QOP · 6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14460.730.8240QOP
25470.720.8051QOP
32910.660.8237empty
41670.520.7925empty
5520.380.8116empty

Interfaces

1 interface between chains.

  • A–B · 1154 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 6V34 · Crystal structure of BRAF V600E oncogenic mutant in complex with TAK-580 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.